Of importance, several of the novel anti-depression drugs which are assessed in animal models of ‘sickness behaviour’ and in human depression clinical trials can suppress inflammation via a SAPK/MAPK and/or JAK/STAT signalling, at least in vitro.37 Here, MAPK9 is linked to depressive disorder.